| Literature DB >> 31742493 |
Yu Dong1, Xiaosheng Qu2, Gang Wu1, Xiangdong Luo1, Botao Tang1, Fangfang Wu2, Lanlan Fan3, Sooranna Dev4, Taisheng Liang1.
Abstract
Chronic Kidney Disease (CKD) is characterized by the gradual loss of renal mass and functions. It has become a global health problem, with hundreds of millions of people being affected. Both its incidence and prevalence are increasing over time. More than $20,000 are spent on each patient per year. The economic burden on the patients, as well as the society, is heavy and their life quality worsen over time. However, there are still limited effective therapeutic strategies for CKD. Patients mainly rely on dialysis and renal transplantation, which cannot prevent all the complications of CKD. Great efforts are needed in understanding the nature of CKD progression as well as developing effective therapeutic methods, including pharmacological agents. This paper reviews three aspects in the research of CKD that may show great interests to those who devote to bioanalysis, biomedicine and drug development, including important endogenous biomarkers quantification, mechanisms underlying CKD progression and current status of CKD therapy. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.Entities:
Keywords: Chronic kidney disease; biosensors; dietary modification; gut microbiota intervention; pharmacologicalzzm321990agents; progression mechanism.
Mesh:
Substances:
Year: 2019 PMID: 31742493 DOI: 10.2174/1381612825666191119094354
Source DB: PubMed Journal: Curr Pharm Des ISSN: 1381-6128 Impact factor: 3.116